Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Stomach Neoplasms 31Pancreatic Neoplasms 8Colorectal Neoplasms 7Biliary Tract Neoplasms 5Neoplasm Metastasis 4Breast Neoplasms 3Recurrence 2Gastrointestinal Neoplasms 2Carcinoma, Hepatocellular 2Advanced Gastric Cancer 2Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Liver Diseases 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Bile Duct Neoplasms 1Advanced Solid Tumors 1Advanced Biliary Tract Cancer 1

Interventions

Injections 27Carboplatin 18Docetaxel 14pembrolizumab 13Paclitaxel 12Bevacizumab 10durvalumab 8Nivolumab 8Cisplatin 8Fluorouracil 7Pemetrexed 6Oxaliplatin 6Leucovorin 6trifluridine tipiracil drug combination 5toripalimab 5tislelizumab 5linifanib 5Capecitabine 5zimberelimab 4talazoparib 4olaparib 4fludarabine 4Panobinostat 4Itraconazole 4Irinotecan 4Gemcitabine 4Everolimus 4tremelimumab 3sotorasib 3sintilimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumors × titanium silicide × Clear all
NCT01128998 2015-10-19

Sorafenib Plus S-1 in Advanced Solid Tumors

National Health Research Institutes, Taiwan

Phase 1 Completed
30 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡